It has been suggested that the AMP part of the molecule can be considered to be a kind of "handle" by which the enzyme can "grasp" the coenzyme to switch it between different catalytic centers
J Control Release 319:397406 Kim B-J, Zhou J, Martin B, Carlson OD, Maudsley S, Greig NH, Mattson MP, Ladenheim EE, Wustner J, Turner A (2010) Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides
Partial Disclaimer: The product packaging you receive may be different than pictured here
Follow the prescribing guidance from your doctor
P., Oslin, D
If you experience dose-increase side effects during this phase (nausea returning temporarily after stepping up from 0.25 mg to 0.5 mg, for example), temporarily revert to Phase 1 eating strategies for three to five days until your body adjusts